arrow_back Peptide catalog

monitor_weightMetabolicLipolytic GH fragment

AOD-9604

Also known as Anti-Obesity Drug 9604

Investigational fragment of human growth hormone studied for fat metabolism without classical GH side effects.

Discuss with a physician arrow_forward Browse all peptides

Mechanism of action

How AOD-9604 works

Acts on adipose tissue to favor lipolysis without binding to growth hormone receptors that drive somatic growth signals.

Areas of study

What AOD-9604 is studied for

check
Adjunctive support in body composition protocols
check
Lipolysis modulation under physician supervision

Considerations

Important things your physician will discuss

This is general clinical context — not medical advice. Your evaluation determines whether AOD-9604 is appropriate for you.

info
Investigational status — clinical evidence is still emerging
info
Not a replacement for nutrition, training, or core metabolic therapies

Used in

Protocols that reference AOD-9604

View all protocols arrow_forward

monitor_weightMETABOLIC-01

Weight Management & Metabolic Health

Optimization of insulin sensitivity and body composition through advanced clinical intervention and metabolic monitoring.

View protocol arrow_outward

Related peptides

More from the Metabolic category

Full peptide catalog arrow_forward

GLP-1 / GIP receptor agonist

Semaglutide / Tirzepatide

Incretin-class therapies that modulate appetite, slow gastric emptying, and improve insulin response.

View peptide arrow_outward GHRH analog

Tesamorelin

Growth-hormone-releasing-hormone analog studied for visceral adipose tissue reduction and body composition shifts.

View peptide arrow_outward

Curious whether this peptide fits your protocol?

A licensed Allora physician will review your goals, history, and labs before recommending any therapy.

Start your evaluation Browse all peptides